Literature DB >> 9800965

Gastric cancer in the elderly.

E K Kranenbarg1, C J van de Velde.   

Abstract

The elderly population is expanding and, from the early 1990s, one-quarter of newly diagnosed gastric cancer patients are over 80 years of age. The main risk factors for post-operative complications and mortality are total gastrectomy, radical lymphadenectomy, splenectomy and/or pancreatectomy and these should, therefore, not be practised routinely. Good long-term results can be achieved with careful monitoring of concomitant disease.

Entities:  

Mesh:

Year:  1998        PMID: 9800965     DOI: 10.1016/s0748-7983(98)92062-5

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  8 in total

1.  Adenocarcinoma of the stomach: a review.

Authors:  James M McLoughlin
Journal:  Proc (Bayl Univ Med Cent)       Date:  2004-10

2.  Is palliative resection necessary for gastric carcinoma patients?

Authors:  Dong Yi Kim; Jae Kyoon Joo; Young Kyu Park; Seong Yeob Ryu; Young Jin Kim; Shin Kon Kim; Jae Hyuk Lee
Journal:  Langenbecks Arch Surg       Date:  2007-06-26       Impact factor: 3.445

Review 3.  Lymphadenectomy in elderly/high risk patients: should it be different?

Authors:  Laura Ruspi; Federica Galli; Vincenzo Pappalardo; Davide Inversini; Francesco Martignoni; Luigi Boni; Gianlorenzo Dionigi; Stefano Rausei
Journal:  Transl Gastroenterol Hepatol       Date:  2017-01-21

4.  Linear stapling of the short gastric vessels reduces blood loss and splenectomy at oesophageal and gastric surgery.

Authors:  J F Dowdall; O J McAnena
Journal:  Surg Endosc       Date:  2006-01-19       Impact factor: 4.584

5.  Low Maruyama index surgery for gastric cancer: blinded reanalysis of the Dutch D1-D2 trial.

Authors:  K C M J Peeters; S A Hundahl; E Klein Kranenbarg; H Hartgrink; C J H van de Velde
Journal:  World J Surg       Date:  2005-12       Impact factor: 3.352

6.  Clinicopathological profile and long-term outcome in young adults with gastric cancer: multicenter evaluation of 214 patients.

Authors:  Jan Kulig; Tadeusz Popiela; Piotr Kolodziejczyk; Marek Sierzega; Joanna Jedrys; Antoni M Szczepanik
Journal:  Langenbecks Arch Surg       Date:  2007-07-06       Impact factor: 3.445

7.  Oxaliplatin, 5-FU, folinic acid as first-line palliative chemotherapy in elderly patients with metastatic or recurrent gastric cancer.

Authors:  In Sil Choi; Do-Youn Oh; Byoung-Su Kim; Keun-Wook Lee; Jee Hyun Kim; Jong-Seok Lee
Journal:  Cancer Res Treat       Date:  2007-09-30       Impact factor: 4.679

8.  Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial.

Authors:  D Santini; F Graziano; V Catalano; M Di Seri; E Testa; A M Baldelli; P Giordani; A La Cesa; B Spalletta; B Vincenzi; A Russo; M Caraglia; V Virzi; S Cascinu; G Tonini
Journal:  BMC Cancer       Date:  2006-05-10       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.